Randall Kaye
Chief Tech/Sci/R&D Officer bij LONGBOARD PHARMACEUTICALS, INC.
Vermogen: 397 466 $ op 29-02-2024
Profiel
Currently, Randall E.
Kaye is Chief Medical Officer & EVP at Longboard Pharmaceuticals, Inc. He is also on the board of NervGen Pharma Corp.
In the past he was Chief Medical Officer at Axsome Therapeutics, Inc., Chief Medical Officer of Click Therapeutics, Inc., Chief Medical Officer for Neurana Pharmaceuticals, Inc., Chief Scientific Officer at SSI Strategy LLC, Vice President-Medical Affairs of Scios, Inc., Chief Medical Officer & SVP-Medical Affairs at Avanir Pharmaceuticals, Inc. and Vice President-Medical Affairs of InterMune, Inc.
He received a graduate degree, a doctorate and an undergraduate degree from George Washington University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-02-2024 | 17 920 ( 0.05% ) | 397 466 $ | 29-02-2024 | |
NERVGEN PHARMA CORP.
-.--% | 23-05-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Randall Kaye
Bedrijven | Functie | Begin |
---|---|---|
NERVGEN PHARMA CORP. | Director/Board Member | 28-10-2020 |
LONGBOARD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 21-03-2022 |
Eerdere bekende functies van Randall Kaye
Bedrijven | Functie | Einde |
---|---|---|
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 01-09-2019 |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01-09-2018 |
AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-09-2016 |
AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01-09-2014 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | 01-01-2006 |
Opleiding van Randall Kaye
George Washington University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
AXSOME THERAPEUTICS, INC. | Health Technology |
NERVGEN PHARMA CORP. | Health Technology |
LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY. | Technology Services |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Commercial Services |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |